EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

Katharina Conrad, Ronja Löber-Handwerker, Mohammad Hazaymeh, Veit Rohde, Vesna Malinova

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04683-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Katharina Conrad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Medical Center Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Decision Trees. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Herzzentrum Göttingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Glioblastoma (GBM) is the most frequent glioma in adults with a high treatment resistance resulting into limited survival. The individual prognosis varies depending on individual prognostic factors, that must be considered while counseling patients with newly diagnosed GBM. The aim of this study was to elaborate a risk stratification algorithm based on reliable prognostic factors to facilitate a personalized prognosis estimation early on after diagnosis.

Methods

A consecutive patient cohort with confirmed GBM treated between 2010 and 2021 was retrospectively analyzed. Clinical, radiological, and molecular parameters were assessed and included in the analysis. Overall survival (OS) was the primary outcome parameter. After identifying the strongest prognostic factors, a risk stratification algorithm was elaborated with estimated odds of survival.

Results

A total of 462 GBM patients were analyzed. The strongest prognostic factors were Charlson Comorbidity Index (CCI), extent of tumor resection, and adjuvant treatment. Patients with CCI ≤ 1 receiving tumor resection had the highest survival odds (88% for 10 months). On the contrary, patients with CCI > 3 receiving no adjuvant treatment had the lowest survival odds (0% for 10 months). The 10-months survival rate in patients with CCI > 3 receiving adjuvant treatment was 56% for patients younger than 70 years and 22% for patients older than 70 years.

Conclusion

A risk stratification algorithm based on significant prognostic factors allowed a personalized early prognosis estimation at the time of GBM diagnosis, that can contribute to a more personalized patient counseling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsDecision TreesHumansMaleFemalePrognosisMiddle AgedAgedRetrospective StudiesAdultSurvival RatePrecision MedicineAlgorithmsAged, 80 and overRisk AssessmentFollow-Up Studies

Stichwörter der Autor:innen

GlioblastomaPrognostic factorsSurvival analysis

Autor:innen und Institutionen

  • Department of Neurosurgery, University Medical Center Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany.
  • Department of Neurosurgery, University Medical Center Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany. vesna.malinova@gmail.com.

Förderung

  • Herzzentrum Göttingen

Zitieren

APA

Conrad, K., Löber-Handwerker, R., Hazaymeh, M., Rohde, V., & Malinova, V. (2024). Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04683-6

Vancouver

Conrad K, Löber-Handwerker R, Hazaymeh M, Rohde V, Malinova V. Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04683-6

BibTeX
@article{Conrad2024,
  author = {Conrad, Katharina and Löber-Handwerker, Ronja and Hazaymeh, Mohammad and Rohde, Veit and Malinova, Vesna},
  title = {Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04683-6}
}
Kostenlos starten →